Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Consolidated Net Income (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Consolidated Net Income of -$10.74 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$19.4 million a year earlier.

Analysis

Vistagen Therapeutics (VTGN) Consolidated Net Income (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Consolidated Net Income at Vistagen Therapeutics was -$58.97 million; for FY2026 (ended Mar 31, 2026), it was -$69.69 million.

  • In prior fiscal years, Vistagen Therapeutics' Consolidated Net Income was -$51.41 million in FY2025, -$29.36 million in FY2024, -$59.25 million in FY2023 and -$47.76 million in FY2022.
  • The fiscal Q2 2027 figure stands as the highest quarterly Consolidated Net Income since fiscal Q1 2025.
  • According to Business Quant data, Consolidated Net Income for the three prior fiscal quarters was -$13.04 million (Q1 2027), -$16.29 million (Q4 2026) and -$18.9 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -1.95 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 6.45 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 210.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 4.22 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 5.07 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 2.43 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -10.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -10.74 Mn
Jun 30, 2026 -13.04 Mn
Mar 31, 2026 -16.29 Mn
Dec 31, 2025 -18.90 Mn
Sep 30, 2025 -19.40 Mn
Jun 30, 2025 -15.10 Mn
Mar 31, 2025 -13.64 Mn
Dec 31, 2024 -14.10 Mn
Sep 30, 2024 -12.94 Mn
Jun 30, 2024 -10.73 Mn
Mar 31, 2024 -9.52 Mn
Dec 31, 2023 -6.35 Mn
Sep 30, 2023 -6.59 Mn
Jun 30, 2023 -6.90 Mn
Mar 31, 2023 -12.23 Mn
Dec 31, 2022 -9.76 Mn
Sep 30, 2022 -17.48 Mn
Jun 30, 2022 -19.78 Mn
Mar 31, 2022 -16.69 Mn
Dec 31, 2021 -10.53 Mn
API Access

Vistagen Therapeutics Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=VTGN&period=max&api_key=YOUR_API_KEY